What is CTXR's dilution risk score?

CTXR has a latest available DilutionScore record of 48/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for CTXR, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for CTXR?

DilutionWatch tracks 25 SEC filing types for CTXR including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CTXR shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CTXR, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CTXR tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CTXR. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CTXR Dilution Risk Score: 48/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

50

💰 Cash Runway

65

📊 Float Risk

20

⚠️ Warrant Exposure

50

🔄 Convertible Debt

15

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 47%

🔄 Reverse Split model est. 65%

• 50-day avg $0.74 below $1 exchange minimum

• 7 months cash with weak price

💰 Capital Raise model 33%

• Under 12 months cash (7mo)

• Active ATM program with $250M remaining capacity

📜 Warrant Exercise model 25%

• Significant warrants: 19% of shares outstanding

🔔 Track CTXR — Get forecast alerts →

Market Data

Market Cap$17.98M

Shares Outstanding27.45M

Float26.96M

Cash$17.01M

Debt$808.2K

Short InterestN/A

Institutional Holdings

QoQ: ↑ 113.4% shares (2026Q1 vs prior)

15 institutional holders · 14.78M shares

#1 ARMISTICE CAPITAL, LLC 9.19M shares

#2 BANK OF AMERICA CORP /DE/ 3.84M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 1.07M shares

+ 12 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.16M

Days to Cover8.2

% of Float19.1%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-09-10

xbrl XBRL CONVERTIBLE 2016-09-30

8-K 8K EVENT 2026-04-24

424B5 ATM 2026-04-24

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual CTXR Dilution Snapshot

Citius Pharmaceuticals, Inc. (CTXR) has a DilutionScore of 48/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $250.0M.
Stored outstanding warrants: 5.1M.
Recent SEC activity tracked for CTXR: 8-K on 2026-04-24; 424B5 on 2026-04-24; xbrl on 2025-09-10.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.